NEW YORK, August 14, 2025--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced the discontinuation of the clinical development program for SGR-2921, its CDC7 inhibitor, which was being ...
Stochastic nonlinear wave equations and Schrödinger equations represent a fascinating confluence of probability theory and the analysis of partial differential equations. By incorporating random ...